PolyPid share price logo

PolyPid Share Price

NASDAQ: PYPD

Small Cap

$4.70

-0.04

(-0.95%)

as on

PolyPid Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.69
    $4.80
    downward going graph

    0.21%

    Downside

    2.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.44
    $5.12
    downward going graph

    48.09%

    Downside

    8.94%

    Upside

    downward going graph

PolyPid share price movements today

Previous Close
$4.74
Open
$4.77
Volume
348.7K
Day's Low - High
$4.69 - $4.80
52 Week Low - High
$2.44 - $5.12

PolyPid Historical Returns

1 Month Return
+ 13.94 %
3 Month Return
+ 6.28 %
1 Year Return
+ 72.99 %
3 Year Return
-62.37 %
5 Year Return
-98.35 %

PolyPid Stock Fundamentals & Key Indicators

Check PolyPid market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$90.5M

EPS (TTM)

-1.475

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-31.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-366.29%

PolyPid vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PolyPid with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$90.5M-98.35%NA0.00%
BUY$41.3B127.64%133.478.45%
BUY$112.2B100.4%28.8232.94%
NA$37.2BNA131.655.37%
BUY$79.4B48.8%18.0831.41%

Stock Returns calculator for PolyPid Stock including INR - Dollar returns

The PolyPid stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PolyPid investment value today

Current value as on today

₹1,87,496

Returns

₹87,496

(+87.5%)

Returns from PolyPid Stock

₹71,533 (+71.53%)

Dollar Impact

₹15,963 (+15.96%)

Analyst Recommendation on PolyPid Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for PolyPid. Average target price of $12.25

PolyPid Share Price Target

Get share price movements and forecasts by analysts on PolyPid.

What analysts predicted

61.63%UPSIDE

Target Price

$12.25

Current Price

$4.7

Analyzed by

9 Analysts

Target

$12.25

PolyPid target price $12.25, a slight upside of 61.63% compared to current price of $4.7. According to 9 analysts rating.

PolyPid Stock’s Investor Sentiment and Interest

Search interest for PolyPid Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

PolyPid Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-5
-5
-6
-6
-7
-8
-7
-9
-7
8
EBITDA
-5
-5
-6
-6
-7
-8
-7
-9
-7
-8
Interest Expense
0
0
0
0
0
0
0
0
-
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-5
-6
-6
-6
-7
-8
-8
-9
-7
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-5
-6
-6
-6
-7
-8
-8
-9
-7
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PolyPid Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-1
-1
-1
-1
-1
-
Operating Income
-10
-13
-18
-18
-26
-42
-38
-22
-28
-32
EBITDA
-10
-13
-42
-5
-25
-41
-37
-21
-26
-31
Interest Expense
0
0
0
0
0
87
1
1
1
0
Depreciation
-
0
0
0
1
1
1
1
1
1
Income Before Tax
-11
-54
5
-6
-36
-42
-39
-23
-28
-34
Income Tax Expense
1
40
-24
-11
-1
-1
0
0
0
0
Net Income
-11
-54
5
-6
-35
-40
-39
-23
-29
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PolyPid Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-6
-6
-7
-8
-8
-9
-7
-8
Operating Cash Flow
-
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
3
-
-
-
-
-13
15
-7
-3

PolyPid Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-54
5
-6
-36
-42
-39
-23
-29
-34
Operating Cash Flow
-12
-16
-17
-21
-32
-34
-17
-21
-27
Investing Cash Flow
-8
10
-23
-40
36
16
3
0
-
Financing Cash Flow
14
9
37
62
1
16
9
32
25
Change in Cash
-6
3
-3
0
5
-1
-3
10
-9

Global Institutional Holdings in PolyPid

Funds
Holdings
Citadel Advisors Llc
0.06%
HighTower Advisors, LLC
0.05%
Steward Partners Investment Advisory, LLC
0.04%
Northwestern Mutual Wealth Management Co
0.02%
TD Waterhouse Canada Inc
0%

Insights on PolyPid

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PYPD stock has moved up by 7.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PYPD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 88.6%

About PolyPid

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
OrganisationPolyPid
Headquarters18 Hasivim Street, Petah Tikva, Israel, 4959376
IndustryBiotechnology
CEOMs. Dikla Czaczkes Akselbrad
E-voting on sharesClick here to vote

Key Management of PolyPid

Name

Title

Ms. Dikla Czaczkes Akselbrad

CEO & Director

Mr. Jonny Missulawin

Chief Financial Officer

Mr. Tal Vilnai

General Counsel & Corporate Secretary

Dr. Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Ms. Dalit Hazan

Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs

Mr. Ori Warshavsky

Chief Operating Officer - US

Ms. Maria Rubin

Executive Vice President of Operations

Ms. Rivi Lev-ari

Vice President of Human Resource

Dr. Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

FAQs

What is PolyPid share price today?

PolyPid share price today is $4.7 as on at the close of the market. PolyPid share today touched a day high of $4.8 and a low of $4.69.

What is the 52 week high and 52 week low for PolyPid share?

PolyPid share touched a 52 week high of $5.12 on and a 52 week low of $2.44 on . PolyPid stock price today i.e. is closed at $4.7,which is 8.20% down from its 52 week high and 92.62% up from its 52 week low.

What is PolyPid's market capitalisation today?

PolyPid market capitalisation is $0.00T as on .

How to invest in PolyPid Stock (PYPD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PolyPid on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PolyPid Shares that will get you 0.3191 shares as per PolyPid share price of $4.7 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy PolyPid Stock (PYPD) from India?

Indian investors can start investing in PolyPid (PYPD) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in PolyPid stock (as per the Rupee-Dollar exchange rate as on ). Based on PolyPid share’s latest price of $4.7 as on April 21, 2026 at 1:29 am IST, you will get 2.1277 shares of PolyPid. Learn more about fractional shares .

What are the returns that PolyPid has given to Indian investors in the last 5 years?

PolyPid stock has given -98.35% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?